Filings (90d)
Other insiders active in the same sector
No other insider has filed at BridgeBio Pharma LLC's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is BridgeBio Pharma LLC?
BridgeBio Pharma LLC is a corporate entity of BridgeBio Oncology Therapeutics, Inc. (BBOT). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did BridgeBio Pharma LLC last file a Form 4?
The only primary Form 4 on record is dated 10 October 2025.
